SAM
SWAV

Silvercrest Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Silvercrest Asset Management’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-881
Closed -$245K – 823
2022
Q3 		$245K Sell
881
-365
-29% -$92.8K ﹤0.01% 733
2022
Q2 		$238K Sell
1,246
-669
-35% -$118K ﹤0.01% 752
2022
Q1 		$397K Buy
+1,915
New +$316K ﹤0.01% 717

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Silvercrest Asset Management's SWAV Position: Q4 2022 in Review

Silvercrest Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2022, closing a stake of 881 shares — an estimated $245K sold.

Silvercrest Asset Management first reported a position in SWAV in Q1 2022 and held it in 3 quarters. The position peaked at $397K in Q1 2022. 415 funds tracked by Wall St. Rank hold SWAV as of Q4 2022.

  • Silvercrest Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Silvercrest Asset Management sold 881 Shockwave Medical, Inc. Common Stock shares in Q4 2022, an estimated $245K.
  • Silvercrest Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Silvercrest Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $397K in Q1 2022.
  • 415 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2022.

Based on Silvercrest Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.